Kanaph Therapeutics Inc. (KOSDAQ:0082N0)
South Korea
· Delayed Price · Currency is KRW 38,000
-1,500 (-3.80%)
At close: Apr 28, 2026
Kanaph Therapeutics Market Cap
Kanaph Therapeutics has a market cap or net worth of 497.53 billion as of April 29, 2026.
Market Cap
497.53B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
38,000.00
Market Cap Chart
Since March 16, 2026, Kanaph Therapeutics's market cap has decreased from 655.58B to 497.53B, a decrease of -24.11%. That is a compound annual growth rate of -90.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 497.53B | -24.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 430.69B |
| S.Biomedics | 424.81B |
| IntoCell | 597.87B |
| Kangstem Biotech | 386.56B |
| Y-Biologics | 371.10B |
| curacle co.,ltd. | 353.43B |
| NIBEC | 314.32B |
| TiumBio | 308.23B |